Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

ClinicalTrials.gov ID: NCT01199562

Public ClinicalTrials.gov record NCT01199562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 7, 2026, 12:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Modified Preemptive CMV Management Strategy After Allogeneic Hematopoietic Cell Transplantation and Laboratory Correlation With Innate Immune Function

Study identification

NCT ID: NCT01199562
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: City of Hope Medical Center; Other
Enrollment: 153 participants

Conditions and interventions

Conditions

Interventions

DNA analysis Genetic
RNA analysis Genetic
antiviral therapy Procedure
flow cytometry Other
foscarnet sodium Drug
ganciclovir Drug
infection prophylaxis and management Procedure
laboratory biomarker analysis Other
management of therapy complications Procedure
polymerase chain reaction Genetic
protein expression analysis Genetic
valganciclovir Drug

Genetic · Procedure · Other + 1 more

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2010
Primary completion: Dec 29, 2013
Completion: Nov 30, 2026
Last update posted: Jan 27, 2026

2010 – 2026

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
City of Hope Medical Center	Duarte	California	91010	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01199562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 27, 2026 · Synced May 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01199562 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →